RXRA and colorectal carcinoma: This confirms earlier observations of the aberrant expression of β-catenin, upregulated by suppression of RXRα [150] as well as direct interactions between RXRα and β-catenin, which suppress β-catenin transcription and protein expression in CRC cells [151].